Viewing Study NCT04922658


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-25 @ 10:10 PM
Study NCT ID: NCT04922658
Status: RECRUITING
Last Update Posted: 2024-07-31
First Post: 2021-06-06
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Sponsor: Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module